Reports .  In conformity with standard pharmaceutical industry practices and the terms and conditions of this Agreement, Licensee shall prepare and maintain, or shall cause to be prepared and maintained, complete and accurate written records of its Development of the Product s, for a minimum of [***] following the end of the Calendar Year to which they pertain or such longer period of time as may be required by Applicable Law in the Territory .   Within [***] after the end of each Calendar Y ear, Licensee shall provide to Licensor , for its review, an updated version of the Development Plan consisting of (a) an update on the progress of Licensee ' s Development activities, including (i) key achievements or milestones to date in the reporting period, and (ii) studies that were run or are in process and (b) a summary of the planned Development activities for the upcoming Calendar Year.  Such updated Development Plan shall be accompanied by a copy of any Licensee Data generated during the course of prior Calendar Year, but only to the extent that such Licensee Data was not previously provided to Licensor .  Licensee will provide Licensor with an opportunity to review and comment on each updated Development Plan and Licensee will consider in good faith and incorporate the comments of Licensor into such Development Plan to the extent reasonably acceptable to Licensee .